VIVEbiotech strengthens its international presence at the BIO International Convention in San Diego
The company marks its third day by advancing strategic connections and showcasing its lentiviral vector capabilities
VIVEbiotech continues its participation in the BIO International Convention, one of the leading global events in the biotechnology sector, reaching its third day at the San Diego Convention Center.
During the event, the company is strengthening its international network and generating new collaboration opportunities with biopharmaceutical companies, partners, and investors. This key environment allows VIVEbiotech to further consolidate its position in the advanced therapies field.
In this context, the VIVEbiotech team attended the Ampersand Portfolio Company Networking Event, hosted by Ampersand Capital Partners, a highly valuable opportunity to connect with other companies within the ecosystem. The company would like to thank Ampersand Capital Partners for the invitation and highlight the importance of such productive gatherings in fostering meaningful exchanges and building strong synergies.
In addition, VIVEbiotech is present at the ICEX – Spain Trade & Investment Pavilion, where it is showcasing its capabilities in lentiviral vector development and manufacturing for both ex vivo and in vivo applications, contributing to the advancement of innovative gene therapies.
The team on site includes Jon Alberdi (CEO), Natalia Elizalde (Chief Business Development Officer), and Peter Jähn (Vice President, Business Development), who continue to hold strategic meetings during the final days of the convention.
VIVEbiotech invites all interested parties to connect via the BIO partnering platform, its website, or direct contact channels to explore potential collaboration opportunities before the event concludes.